STUDIES SHOW APO A-I MILANO GENE TRANSFER AND ANTIBODY THERAPY CUT ATHEROSCLEROTIC PLAQUE
Cardiology researchers at Cedars-Sinai are studying several approaches to interrupt the events leading to the formation and rupture of atherosclerotic plaque in blood vessels. According to a recent animal study of a new gene therapy, a single injection led to a significant reduction in plaque and moderation of an immune response that contributes to plaque buildup and rupture. Another study found that the administration of certain antibodies significantly reduced pre-existing plaque deposits.
MINIMALLY INVASIVE SURGERY MAY INCREASE OPTIONS FOR OCTOGENARIANS WITH SOME LUNG CANCERS
While some patients, including the elderly, may not be good candidates for the physical demands of open chest surgery, a new study suggests that even those between the ages of 80 and 94 may benefit from video-assisted thoracoscopic surgery (VATS) for early stage, localized, non-small cell lung cancer.
IBS STUDY SHOWS THAT TARGETED ANTIBIOTICS LEAD TO LONG-LASTING IMPROVEMENT IN SYMPTOMS
Researchers at Cedars-Sinai have found that a nonabsorbable antibiotic one that stays in the gut may be an effective long-term treatment for irritable bowel syndrome (IBS). The findings, which showed that participants benefited from the antibiotic use even after the course of treatment ended, support previously published research identifying small intestine bacterial overgrowth (SIBO) as a possible cause of th
Contact: Sandy Van
Cedars-Sinai Medical Center